Sort by:
Helpfulness
|
Most Recent
5 patient evaluations
for
Valcyte
Purpose:
Prevent infection
(Started Sep 02, 2010)
| Date |
Dosage |
Perceived effectiveness |
Side Effects |
Adherence |
Burden |
| Mar 15, 2011 |
900 mg
Daily
|
?Can't tell
|
   Mild
|
   Always
|
   Not at all
|
-
-
0 helpful marks
Purpose:
Prevent infection
(Started Feb 09, 2010)
| Date |
Dosage |
Perceived effectiveness |
Side Effects |
Adherence |
Burden |
| Feb 08, 2011 |
900 mg
Daily
|
   Major
|
   None
|
   Always
|
   Not at all
|
-
-
0 helpful marks
Purpose:
donor positive for CMV
(Started Nov 13, 2010)
| Date |
Dosage |
Perceived effectiveness |
Side Effects |
Adherence |
Burden |
| Nov 25, 2010 |
450 mg
Daily
|
   Major
|
   None
|
   Always
|
   Not at all
|
-
-
0 helpful marks
Purpose:
Prevent infection
(Started Mar 27, 2010)
| Date |
Dosage |
Perceived effectiveness |
Side Effects |
Adherence |
Burden |
| Jul 15, 2010 |
900 mg
Daily
|
?Can't tell
|
   Mild
|
   Always
|
   Not at all
|
-
-
0 helpful marks
Purpose:
Chronic Epstein Barr
(Started Jan 28, 2010)
| Date |
Dosage |
Perceived effectiveness |
Side Effects |
Adherence |
Burden |
| Mar 28, 2010 |
450 mg
Daily
|
   Major
|
   None
|
   Always
|
   Not at all
|
-
-
0 helpful marks
20 additional evaluations
for
Valcyte
are
not currently shared publicly.